Korian SA is a leading European company specializing in the senior care sector. The company's business model revolves around providing high-quality and personalized care services to the aging population. Korian SA operates a wide range of facilities including nursing homes, assisted living residences, and home care services. By focusing on professional and compassionate care, Korian SA aims to enhance the well-being and autonomy of seniors while meeting their specific needs. With a strong commitment to innovation and expertise, Korian SA continues to play a pivotal role in shaping the future of the senior care industry.

Korian SA is primarily active in the healthcare industry, specifically in the field of elderly care and support services. As one of the leading European providers, Korian specializes in offering a range of services such as residential care, nursing homes, and assisted living facilities. With a focus on enhancing the quality of life for seniors, Korian SA aims to provide comprehensive and personalized care solutions. This holistic approach allows the company to cater to the evolving needs of the aging population and maintain its prominent position in the healthcare sector.

The main competitors of Korian SA in the market are Orpea SA and Colisée Group.

Korian SA, a leading European care services company, has an extensive history and background. Established in 2003, Korian has rapidly expanded to become a trusted provider of elderly and healthcare services. With a presence in France, Germany, Belgium, Italy, the Netherlands, and Spain, Korian offers a wide range of care solutions, including nursing homes, assisted living facilities, and home care services. The company focuses on maintaining residents' well-being and quality of life through its personalized approach and commitment to professional and compassionate care. Korian SA continually strives to innovate and improve its services to meet the ever-evolving needs of its customers.

Korian SA, a prominent company in the healthcare sector, has achieved several significant milestones. Over the years, Korian has successfully established itself as a leader in Europe's elderly care and support services. The company has experienced substantial growth, expanding its presence through strategic acquisitions and partnerships across multiple countries. Korian's commitment to providing high-quality care and innovative solutions has been recognized through numerous awards and accolades. With its strong operational performance and focus on patient-driven care, Korian SA continues to make significant strides in improving the lives of seniors and enhancing the overall healthcare industry.

Korian SA is primarily present in several countries and regions. These include France, Germany, Italy, Belgium, Spain, and the Netherlands. With its strong presence in these countries, Korian SA has established itself as a leading healthcare group specializing in elderly care services. The company's extensive network and expertise in managing nursing homes, post-acute care, and assisted living facilities have made it a trusted name in the industry.

Analysts currently set an average price target of 4.51 EUR for the Clariane stock (median: 4.64 EUR), implying +12.9 % versus the latest price. The consensus is based on 15 analyst ratings.

Clariane Analyst Price Targets 2026

15 analysts currently rate the Clariane stock: 11 recommend buying, 3 holding and 1 selling. For 2026, analysts expect Clariane to generate revenue of 5.39 B EUR and earnings per share of 0.11 EUR.

Clariane Analyst Price Targets 2026

The Clariane share (CLARI.PA) is listed on 5 stock exchanges, including: Frankfurt (KO2.F), Düsseldorf (KO2.DU), London (0OPS.L), Paris (KORI.PA).

Korian SA is a French company specializing in providing care and support services for older people, people with disabilities, and people with mental illnesses. The company was founded in 2003 and is headquartered in Paris. It is currently the largest provider of nursing homes in Europe, operating around 850 care facilities in France, Germany, Belgium, Italy, Spain, and the Netherlands. Korian's business model focuses on offering high-quality, tailored care and support services to meet the individual needs of each customer. Their goal is to ensure high-quality care while promoting the independence and autonomy of their customers. The Korian group offers a wide range of different care and support services to meet the diverse needs of their customers. Their products include residential care facilities, day and night centers, home care, socio-educational facilities, and care facilities for people with mental illnesses. The company relies on advanced technology and innovative care concepts to guarantee the highest quality of services. Korian is divided into three main business areas: Korian France, Korian Germany, and Korian International. Korian France is the largest business area, operating around 300 care facilities in France. Korian Germany is the second-largest business area, operating around 250 care facilities in Germany. Korian International is the smallest business area, operating around 300 care facilities in Europe. Korian adopts a decentralized management structure that allows each business area to operate independently and respond to the needs of local markets. The company is known for its continuous investments in innovation and research, with the aim of providing customers with the latest technology in care and support. Another important aspect of Korian's business model is close cooperation with local communities and the public to create a safe and pleasant environment. The company also supports social and ecological sustainability criteria and promotes the integration of people with disabilities and older people into society. Overall, Korian's business model is focused on providing high-quality care and support. The company offers a wide range of products and services tailored to the individual needs of its customers, while placing social and ecological sustainability, innovation, and research at the forefront.

The expected revenue of Clariane is 5.39 B EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Clariane is 39.24 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Clariane is currently 36.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Clariane stock.

The price-to-sales ratio (P/S) of Clariane is currently 0.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Clariane stock.

The Eulerpool Quality Score for Clariane is 6/10.

The ISIN of Clariane is FR0010386334. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Clariane is A0LE05. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Clariane is CLARI.PA. The ticker symbol is used to trade Clariane shares on the stock exchange.

Over the past 12 months, Clariane paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Clariane is expected to pay a dividend of 0.25 EUR.

The current dividend yield of Clariane is 6.24 %.

Clariane pays a dividend, distributed in the months of , , , .

Clariane paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.25 EUR are expected. This corresponds to a dividend yield of 6.27 %.

Clariane is assigned to the 'Health' sector.

To receive the latest dividend of Clariane from amounting to 0.25 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Clariane are distributed in EUR.